help button home button Endocrine Society Endocrine Reviews
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Purchase Article
Right arrow View Shopping Cart
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Copyright Permission
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Slover, R. H.
Right arrow Articles by Eisenbarth, G. S.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Slover, R. H.
Right arrow Articles by Eisenbarth, G. S.
Endocrine Reviews 18 (2): 241-258
Copyright © 1997 by The Endocrine Society

Prevention of Type I Diabetes and Recurrent ß-Cell Destruction of Transplanted Islets1

Robert H. Slover and George S. Eisenbarth

Barbara Davis Center for Childhood Diabetes, University of Colorado Health Sciences Center, Denver, Colorado 80262

I. Introduction
II. Disease Pathogenesis
III. Disease Prediction
A. Genetic prediction
B. Immunological prediction
C. Metabolic prediction
IV. Prevention of Type I Diabetes
A. Trial design
B. Genetic prevention
C. Prevention: preautoimmunity
D. Prevention: postautoimmunity/prediabetes
E. New onset patients/prevention of further ß-cell destruction
F. Pancreas and islet cell transplantation/prevention of recurrent diabetes
G. Islet cell transplantation/prevention of ß-cell destruction
V. Conclusion




This article has been cited by other articles:


Home page
Diabetes CareHome page
A. Hanukoglu, A. Mizrachi, I. Dalal, O. Admoni, Y. Rakover, Z. Bistritzer, A. Levine, E. Somekh, D. Lehmann, M. Tuval, et al.
Extrapancreatic Autoimmune Manifestations in Type 1 Diabetes Patients and Their First-Degree Relatives: A multicenter study
Diabetes Care, April 1, 2003; 26(4): 1235 - 1240.
[Abstract] [Full Text] [PDF]


Home page
Endocr. Rev.Home page
C. Betterle, C. Dal Pra, F. Mantero, and R. Zanchetta
Autoimmune Adrenal Insufficiency and Autoimmune Polyendocrine Syndromes: Autoantibodies, Autoantigens, and Their Applicability in Diagnosis and Disease Prediction
Endocr. Rev., June 1, 2002; 23(3): 327 - 364.
[Abstract] [Full Text] [PDF]


Home page
Diabetes CareHome page
I. Weets, I. H. De Leeuw, M. V.L. Du Caju, R. Rooman, B. Keymeulen, C. Mathieu, R. Rottiers, J.-C. Daubresse, D. Rocour-Brumioul, D. G. Pipeleers, et al.
The Incidence of Type 1 Diabetes in the Age Group 0-39 Years Has Not Increased in Antwerp (Belgium) Between 1989 and 2000: Evidence for earlier disease manifestation
Diabetes Care, May 1, 2002; 25(5): 840 - 846.
[Abstract] [Full Text] [PDF]


Home page
Ann. N. Y. Acad. Sci.Home page
D. PIPELEERS, B. KEYMEULEN, L. CHATENOUD, C. HENDRIECKX, Z. LING, C. MATHIEU, B. ROEP, and D. YSEBAERT
A View on Beta Cell Transplantation in Diabetes
Ann. N.Y. Acad. Sci., April 1, 2002; 958(1): 69 - 76.
[Abstract] [Full Text] [PDF]


Home page
Ann. N. Y. Acad. Sci.Home page
C. BETTERLE, A. C. SPADACCINO, F. PRESOTTO, R. ZANCHETTA, B. PEDINI, M. LAI, N. A. GREGGIO, and G. F. BOTTAZZO
The Number of Markers of Pancreatic Autoimmunity Is Proportional to the Risk for Type 1 Diabetes Mellitus in Italian and English Patients with Organ-Specific Autoimmune Diseases
Ann. N.Y. Acad. Sci., April 1, 2002; 958(1): 276 - 280.
[Abstract] [Full Text] [PDF]


Home page
DiabetesHome page
E. Bosi, S. Braghi, P. Maffi, M. Scirpoli, F. Bertuzzi, G. Pozza, A. Secchi, and E. Bonifacio
Autoantibody Response to Islet Transplantation in Type 1 Diabetes
Diabetes, November 1, 2001; 50(11): 2464 - 2471.
[Abstract] [Full Text] [PDF]


Home page
Diabetes CareHome page
F. Winnock, M. R. Christie, M. R. Batstra, H.-J. Aanstoot, I. Weets, K. Decochez, P. Jopart, D. Nicolaij, and F. K. Gorus
Autoantibodies to a 38-kDa Glycosylated Islet Cell Membrane-Associated Antigen in (Pre)type 1 Diabetes: Association with IA-2 and islet cell autoantibodies
Diabetes Care, July 1, 2001; 24(7): 1181 - 1186.
[Abstract] [Full Text] [PDF]


Home page
Ann. N. Y. Acad. Sci.Home page
G. R. RAYAT, R. V. RAJOTTE, and G. S. KORBUTT
Potential Application of Neonatal Porcine Islets as Treatment for Type 1 Diabetes: A Review
Ann. N.Y. Acad. Sci., June 18, 1999; 875(1): 175 - 188.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Endocrinology Endocrine Reviews J. Clin. End. & Metab.
Molecular Endocrinology Recent Prog. Horm. Res. All Endocrine Journals
Copyright © 1997 by The Endocrine Society